New ovarian cancer study to probe causes of PARP inhibitor resistance

Professor David Williams (UCL EGA Institute for Womens Health) said that a new study by Glasgow University has “exciting implications for clinical practice, paving the way for better management of advanced ovarian cancer through more personalised targeted care.”
Read: Herald (Scotland)